During a scheduled initial prenatal evaluation, a pregnant patient at 9 weeks of gestation… — USMLE Step 2 CK

During a scheduled initial prenatal evaluation, a pregnant patient at $9$ weeks of gestation undergoes routine laboratory screening. The patient is $26$ years old, has never been pregnant before, and reports only mild early morning nausea. Her medical history is unremarkable, and she denies any palpitations, tremors, weight loss, or heat intolerance. On physical examination, her vital signs are blood pressure $112/68 \text{ mm Hg}$ , pulse $78/\text{min}$ , and respiratory rate $14/\text{min}$ . The thyroid gland is normal in size without palpable nodules or tenderness. A thyroid function panel reveals a thyroid-stimulating hormone (TSH) level of $0.2 \text{ \mu U/mL}$ (non-pregnant reference range: $0.4-4.0 \text{ \mu U/mL}$ ) and an elevated total thyroxine (T4) level. Her free T4 level is within normal limits. Which of the following is the most appropriate next step in the management of this patient's thyroid findings?

A
Initiate therapy with low-dose propylthiouracil
B
Measure serum thyroid-stimulating immunoglobulin titers
Proceed with routine prenatal care without targeted thyroid interventionsCevap
D
Start empirical levothyroxine supplementation
E
Order a radioactive iodine uptake scan

Cevap

Proceed with routine prenatal care without targeted thyroid interventions

The correct answer is to proceed with routine prenatal care because the patient's laboratory findings represent normal, expected physiological adaptations to pregnancy. During the first trimester, circulating levels of human chorionic gonadotropin (hCG) peak. Because hCG shares structural homology (an identical alpha subunit) with TSH, it can directly stimulate the TSH receptor on the thyroid gland. This leads to a mild, transient increase in thyroid hormone production, which subsequently suppresses TSH secretion via negative feedback. Simultaneously, rising estrogen levels stimulate the hepatic synthesis of thyroxine-binding globulin (TBG). This increases the serum pool of total T4. However, the biologically active free T4 typically remains within the normal reference range, keeping the patient clinically euthyroid. Given the absence of hyperthyroid symptoms, a normal physical examination, and a normal free T4 level, no medical intervention or pathological workup is indicated.

Adım Adım Çözüm

Interpret the patient's laboratory results in the context of her pregnancy.

The patient has a suppressed TSH, elevated total T4, and normal free T4 at 9 weeks gestation.

Accurate interpretation of thyroid panels during pregnancy is critical to differentiate physiological changes from pathology.

Correlate the laboratory findings with the patient's clinical presentation.

The patient is completely asymptomatic for hyperthyroidism and lacks physical examination findings such as goiter or tachycardia.

Clinical status helps confirm whether abnormal laboratory values represent a true disease state or a benign physiological adaptation.

Identify the physiological mechanism responsible for the findings.

Human chorionic gonadotropin (hCG) mimics TSH, causing transient TSH suppression. Estrogen increases thyroxine-binding globulin (TBG), raising total T4 while keeping free T4 normal.

Understanding the roles of hCG and estrogen prevents misdiagnosis of hyperthyroidism in the first trimester.

Determine the appropriate management.

Because this is a normal physiological state (euthyroid hyperthyroxinemia of pregnancy), no treatment or further diagnostic testing is required.

Unnecessary interventions can cause iatrogenic harm to both the mother and the fetus.

Anahtar Kavram

Normal maternal physiological adaptations to pregnancy include transient TSH suppression in the first trimester (due to hCG peaking) and an increase in total T4 (due to estrogen-induced increases in thyroxine-binding globulin), while free T4 remains normal.

Tahmini Süre:1m 15s

Soru

Cevap

Adım Adım Çözüm

Anahtar Kavram

Sık Yapılan Hatalar

Konular

Bu konudan daha fazla soru